Somewhat Favorable Press Coverage Somewhat Unlikely to Impact EndoChoice Holdings (GI) Stock Price

Headlines about EndoChoice Holdings (NYSE:GI) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. EndoChoice Holdings earned a news impact score of 0.12 on Accern’s scale. Accern also gave headlines about the medical equipment provider an impact score of 46.8285034912802 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Shares of EndoChoice Holdings (NYSE:GI) remained flat at $8.00 during mid-day trading on Monday. EndoChoice Holdings has a one year low of $3.64 and a one year high of $8.03. The company has a 50-day moving average price of $8.00 and a 200-day moving average price of $7.14.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.com-unik.info/2017/10/16/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-endochoice-holdings-gi-stock-price.html.

EndoChoice Holdings Company Profile

EndoChoice Holdings, Inc is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

What are top analysts saying about EndoChoice Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for EndoChoice Holdings Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit